Back to results
US 10,870,854 B2Granted
Inhibitory RNA-based therapeutics targeting ANLN for cancer treatment
AssigneeBoard of Regents, The University of Texas System
InventorsHao Zhu, Shuyuan Zhang
Life of this patent
Estimating the term…
Abstract
Embodiments of the present disclosure include compositions and methods related to certain siRNA compositions for the treatment of cancer. In specific embodiments, siRNAs are employed for treatment of cancer, including at least liver cancer. Therapeutic methods, compositions, and kits are encompassed in the disclosure.
Claims14
A method of treating a liver cancer in a subject comprising administering to the subject an effective amount of an interfering RNA or vector encoding the interfering RNA, where the interfering RNA targets an anillin actin binding protein mRNA.
Dependencies are inferred from the claim text.